Clinical characterization of Japanese children with Cushing's disease

Mari Yamamoto1,2, Yuri Mukoyama1, Kentaro Kishi1

  • 1Department of Pediatrics, Toranomon Hospital, Tokyo 105-8470, Japan.

Endocrine Journal
|July 1, 2026
PubMed

Insights

This study highlights the clinical features of Cushing's disease in Japanese children, noting frequent symptoms like facial changes and obesity. Effective diagnostic methods and high remission rates were observed, with significant improvements in height and BMI standard deviation scores post-treatment.

Area of Science:

  • Pediatric Endocrinology
  • Neuroendocrinology
  • Rare Diseases

Background:

  • Cushing's disease (CD) is exceptionally rare in pediatric populations.
  • Understanding the clinical presentation and diagnostic challenges in children is crucial for timely intervention.

Purpose of the Study:

  • To retrospectively analyze the clinical characteristics, diagnostic approaches, and treatment outcomes of pediatric Cushing's disease in Japanese patients.
  • To evaluate the effectiveness of various diagnostic tests and the impact of treatment on growth parameters.

Main Methods:

  • Retrospective analysis of medical records for 19 children diagnosed with Cushing's disease (age ≤18 years) between 1994 and 2025.
  • Assessment of diagnostic test sensitivities for endogenous hypercortisolism and etiological diagnosis.
  • Evaluation of tumor detection rates via MRI and treatment remission rates.

Main Results:

  • Common symptoms included facial changes, weight gain, central obesity, and hirsutism.
  • Diagnostic screening tests for hypercortisolism demonstrated 100% sensitivity.
  • Etiological diagnosis tests showed high sensitivities (83.3%-93.8%), with a 72.2% tumor detection rate by MRI.
  • A high total remission rate of 94.4% was achieved, with significant improvements in height and BMI standard deviation scores post-treatment.

Conclusions:

  • Cushing's disease in Japanese children presents with distinct clinical features and significant growth disturbances.
  • Standard diagnostic protocols are effective, and treatment leads to substantial clinical and growth improvements.
  • This study provides valuable insights into the management of pediatric Cushing's disease in a Japanese cohort.

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...